✦ LIBER ✦

The antiemetic activity of high-dose alizapride and high-dose metoclopramide in patients receiving cancer chemotherapy: A prospective, randomized, double-blind trial

✍ Scribed by Joss, R A; Galeazzi, R L; Bischoff, A K; Pirovino, M; Ryssel, H J; Brunner, K W

Book ID: 109843859
Publisher: Nature Publishing Group
Year: 1986
Tongue: English
Weight: 480 KB
Volume: 39
Category: Article
ISSN: 0009-9236
DOI: 10.1038/clpt.1986.109

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, double-blind comparison of

A randomized, double-blind comparison of the antiemetic effect of metoclopramide and lorazepam with or without dexamethasone in patients receiving high-dose cisplatin

✍ Suzanne H. Stephens; V. Lee Silvey; Richard H. Wheeler 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 414 KB 👁 2 views

Thirty-seven patients with advanced incurable malignancies who were receiving their first course of cisplatin (2 90 mg/mz bolus), alone or in combination with other antineoplastic agents, were entered in this randomized, double-blind study to determine the antiemetic efficacy of the addition of high

High-dose metoclopramide by infusion: a

High-dose metoclopramide by infusion: a double-blind study of plasma concentration-effect relationships in patients receiving cancer chemotherapy

✍ W. B. Taylor; J. M. Simpson; D. N. Bateman 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 517 KB

A prospective, randomized double-blind t

A prospective, randomized double-blind trial comparing metoclopramide alone with metoclopramide plus dexamethasone in preventing emesis induced by high-dose cisplatin

✍ Purvish M. Parikh; Bishan S. Charak; Shripad D. Banavali; Smriti B. Koppikar; Ne 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 346 KB 👁 2 views

Continuous infusion of high-dose metoclo

Continuous infusion of high-dose metoclopramide for the prevention of nausea and vomiting in patients receiving cancer chemotherapy

✍ R. A. Joss; R. L. Galeazzi; K. W. Brunner 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 580 KB

Risedronate for prevention of bone miner

Risedronate for prevention of bone mineral density loss in patients receiving high-dose glucocorticoids: a randomized double-blind placebo-controlled trial

✍ C. C. Mok; K. H. Tong; C. H. To; Y. P. Siu; K. M. Ma 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 156 KB

Efficacy and safety of high-dose pravast

Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial

✍ James H. Lewis; Mary Ellen Mortensen; Steven Zweig; Mary Jean Fusco; Jeffrey R. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

The hepatotoxic potential of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in patients with underlying chronic liver disease remains controversial. We performed a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial that compared pravastatin (80 mg) to a place